6 important things to know about your COVID-19 vaccine card

Everyone who gets vaccinated for COVID-19 in the U.S. receives a vaccine card. Sarah Lynch, clinical assistant professor of pharmacy practice at Binghamton University, State University of New York, offers insight into why vaccine cards are important and why you…

‘Immunity passports’ for COVID-19 must be distributed equitably

Proof of vaccination against COVID-19 i.e. “immunity passports” promise a way to return to a more normal social and economic life, but the benefits they generate will be dispersed unequally, and it is not obvious that they are ethical, according…

Why COVID-19 vaccine distribution methods fall short and 3 ways to improve them

Several proposals have emerged on how to distribute the COVID-19 vaccine, but they fall short in ensuring that the vaccine is distributed fairly. A team including Binghamton University professor Nicole Hassoun suggests three ways to more fairly and effectively distribute the vaccine so that people in poor countries get the vaccine as soon as possible.

It’s morally wrong for rich nations to hoard COVID-19 vaccine

Rich nations should not engage in “vaccine nationalism” and keep the COVID-19 vaccine to themselves when poorer nations need them, according to Nicole Hassoun, professor of philosophy at Binghamton University, State University of New York.

Pharmacies to play major role in distributing COVID-19 vaccine, sharing information

Your corner pharmacy will play a big role in delivering the COVID-19 vaccine and sharing important info with the public, according to Sarah Lynch, clinical assistant professor of pharmacy practice at Binghamton University, State University of New York. A key…

LifeBridge Health Begins COVID-19 Vaccinations of Front-line Caregivers

LifeBridge Health has begun to administer the COVID-19 vaccine to front-line healthcare workers. The first doses of the newly approved Pfizer COVID vaccine arrived at LifeBridge Health on December 17 with 24 team members receiving the vaccine that afternoon at Sinai Hospital.

Rutgers Expert Available to Discuss Rich Countries Hoarding Coronavirus Vaccine

Richard Marlink, director of the Rutgers Global Health Institute, is available to discuss the global health impact of coronavirus vaccine hoarding by rich countries and how such measures may derail worldwide efforts in fighting the pandemic. “Hoarding of vaccines by…

Nearly Half of Community Health Center Patients Qualify for Phase One COVID-19 Vaccinations

Nearly half of all patients served by community health centers (CHCs) qualify for phase one COVID-19 immunizations under priority guidelines established by the Centers for Disease Control and Prevention, according to a new analysis produced by researchers at the Geiger Gibson/RCHN Community Health Foundation Research Collaborative.

Rutgers Vaccine Expert Available to Discuss Moderna’s FDA Submission

Rutgers’ principal investigator for the Moderna phase 3 coronavirus vaccine clinical trial at Rutgers New Jersey Medical School is available to discuss the drugmaker’s submission of its vaccine to the U.S. Food and Drug Administration for regulatory approval. “It is…

Rutgers Infectious Disease Expert Available to Discuss Moderna’s Coronavirus Vaccine

Rutgers’ principal investigator for the Moderna phase 3 coronavirus vaccine clinical trial at Rutgers New Jersey Medical School is available to discuss the drugmaker’s vaccine, which the company has announced is 94.5 percent effective. Moderna intends to seek an emergency…

Vaccine to prevent tuberculosis may help limit spread of COVID-19, Missouri S&T researchers say

A vaccine developed about a century ago to prevent tuberculosis may also help prevent the transmission of COVID-19, according to two Missouri S&T researchers who examined the spread of COVID-19 among countries that require the vaccine and those that do not.The Missouri S&T researchers analyzed COVID-19-related death and incidence rates among nations that require the BCG (Bacillus Calmette-Guerin) vaccine.

Baylor Scott & White Research Institute Expands Efforts in the Fight Against COVID-19

As the global response to the SARS-COV-2 virus that causes COVID-19 approaches 200 days, Baylor Scott & White Research Institute, the research and development arm of Baylor Scott & White Health, is accelerating its pace of bringing clinical trials online.

Baylor Scott & White Research Institute continues to mobilize staff and resources, including components needed to integrate critical patient-safety measures at every participating site within the Baylor Scott & White system for industry sponsored drug trials, investigator-initiated drug trials and research studies, and observational and data studies designed to help increase knowledge around case trends, viral epidemiology, and care best practices.

UNLV Vaccination Expert Explores How Vaccine Refusal Might Change in Light of COVID-19

As governors across America begin to unveil and deploy plans to reopen their respective states, at the center of the debate a question has emerged: how soon is too soon? Some states, including Nevada and neighboring California, are taking a…

Wichita State University chemist working to develop antiviral drugs in fight against COVID-19

Up until recently, COVID-19 (coronavirus disease 2019) may have been a relatively new phenomena to the general public, but Wichita State University medical chemist Bill Groutas, two virologists from Kansas State University, and a physician/virologist from the University of Iowa have been working on a cure for coronaviruses for more than three years.

Understanding How COVID-19 Affects Children Vital to Slowing Pandemic, Doctors Say

Though COVID-19 so far appears to be largely sparing children, researchers are cautioning that it is critical to understand how the virus affects kids to model the pandemic accurately, limit the disease’s spread and ensure the youngest patients get the care they need.